Unknown

Dataset Information

0

P3H4 Promotes Malignant Progression of Lung Adenocarcinoma via Interaction with EGFR.

ABSTRACT: Lung cancer is associated with the greatest number of cancer-related deaths worldwide. Lung adenocarcinoma (LUAD) accounts for 85% of all cases of lung cancer. Despite recent advances in treatment, the 5-year survival rate remains less than 15%. Thus, the diagnostic and therapeutic role of LUAD remain to be further studied. The prolyl 3-hydroxylase family member 4 (P3H4) is involved in various cancers, but little is known about its role in LUAD. Our study demonstrated that the P3H4 gene was upregulated in LUAD. Clinically, the expression of P3H4 was positively correlated with an advanced TNM stage and shorter survival. Functionally, P3H4 plays a significant role in the metastasis and proliferation of LUAD both in vitro and in vivo. Mechanistically, P3H4 might interact with EGFR to regulate the metabolic substances. Our study indicated that P3H4 is a critical gene in the malignant progression of LUAD and represents a potential biomarker and therapeutic target.

SUBMITTER: Fang C 

PROVIDER: S-EPMC9264976 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

P3H4 Promotes Malignant Progression of Lung Adenocarcinoma via Interaction with EGFR.

Fang Chen C   Liang Yingkuan Y   Huang Yong Y   Jiang Dong D   Li Jiaxi J   Ma Haitao H   Guo Lingchuan L   Jiang Wei W   Feng Yu Y  

Cancers 20220701 13

Lung cancer is associated with the greatest number of cancer-related deaths worldwide. Lung adenocarcinoma (LUAD) accounts for 85% of all cases of lung cancer. Despite recent advances in treatment, the 5-year survival rate remains less than 15%. Thus, the diagnostic and therapeutic role of LUAD remain to be further studied. The prolyl 3-hydroxylase family member 4 (P3H4) is involved in various cancers, but little is known about its role in LUAD. Our study demonstrated that the P3H4 gene was upre  ...[more]

Similar Datasets

Unknown Low-Dose Nicotine Activates EGFR Signaling via α5-nAChR and Promotes Lung Adenocarcinoma Progression.
| S-EPMC7555382 | biostudies-literature
Unknown TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma.
| S-EPMC7066024 | biostudies-literature
Unknown TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target.
| S-EPMC7374170 | biostudies-literature
Unknown Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma.
| S-EPMC7986718 | biostudies-literature
Unknown Upregulated Collagen COL10A1 Remodels the Extracellular Matrix and Promotes Malignant Progression in Lung Adenocarcinoma.
| S-EPMC7726267 | biostudies-literature
Unknown Epsin3 promotes non-small cell lung cancer progression via modulating EGFR stability.
| S-EPMC11800460 | biostudies-literature
Unknown BZW2 promotes malignant progression in lung adenocarcinoma through enhancing the ubiquitination and degradation of GSK3β.
| S-EPMC10904796 | biostudies-literature
Unknown LncRNA H19 Promotes Lung Adenocarcinoma Progression via Binding to Mutant p53 R175H.
| S-EPMC9496924 | biostudies-literature
Unknown LncRNA VPS9D1-AS1 Promotes Malignant Progression of Lung Adenocarcinoma by Targeting miRNA-30a-5p/KIF11 Axis.
| S-EPMC8819668 | biostudies-literature
Unknown Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells.
| S-EPMC6338389 | biostudies-literature